CTS Global Equity Group (PHS:CTS) Research & Development: ₱0.0 Mil (TTM As of Mar. 2026)


PHS:CTS CTS Global Equity Group Inc PHS:CTS
44 GF Score
Price ₱0.36
GF Value ₱0.47
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is CTS Global Equity Group Research & Development?

CTS Global Equity Group PHS:CTS -1.37% 44 Research & Development is ₱0.0 Mil as of Mar. 2026. GuruFocus rates PHS:CTS with a GF Score™ of 44/100 and a GF Value™ of ₱0.47 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CTS Global Equity Group's Research & Development for the three months ended in Mar. 2026 was ₱0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₱0.0 Mil.

CTS Global Equity Group  (PHS:CTS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CTS Global Equity Group Research & Development Related Terms

CTS Global Equity Group Research & Development Historical Data

* Premium members only.

The historical data trend for CTS Global Equity Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTS Global Equity Group Research & Development Chart

CTS Global Equity Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CTS Global Equity Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PHS:CTS
44GF Score
CTS Global Equity Group Inc PHS:CTS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CTS Global Equity Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₱0.0 Mil mean?
CTS Global Equity Group (PHS:CTS) has a Research & Development of ₱0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CTS Global Equity Group and its competitors.
Is CTS Global Equity Group's Research & Development too high?
CTS Global Equity Group's current Research & Development is ₱0.0 Mil. Overall, CTS Global Equity Group has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CTS Global Equity Group's Research & Development compare to MS and GS?
CTS Global Equity Group's Research & Development of ₱0.0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CTS Global Equity Group and its competitors. CTS Global Equity Group's current Research & Development is ₱0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CTS Global Equity Group stock overvalued right now?
Based on GuruFocus' analysis, CTS Global Equity Group (PHS:CTS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₱0.47, compared to a current price of ₱0.36 — trading 23.4% below its estimated fair value. The current Research & Development is ₱0.0 Mil. CTS Global Equity Group's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CTS Global Equity Group (PHS:CTS), the current Research & Development is ₱0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CTS Global Equity Group (PHS:CTS) Overvalued in 2026?

Based on GuruFocus' analysis, CTS Global Equity Group stock appears to be undervalued. The current stock price of ₱0.36 is trading 23.4% below its estimated GF Value™ of ₱0.47. GuruFocus considers CTS Global Equity Group to be Modestly Undervalued.

Key valuation signals for PHS:CTS:

  • Research & Development: ₱0.0 Mil
  • GF Value™: ₱0.47 vs. price of ₱0.36 (23.4% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the PHS:CTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CTS Global Equity Group Business Description

Address Exchange Road, Ortigas Center, 27th floor East Tower, Tektite Towers, Metro Manila, Pasig, PHL, 1605
CTS Global Equity Group Inc. is a stock brokerage firm in the Philippines. The company is engaged as a Broker-Dealer in Securities and Proprietary Trading. It offers its brokerage services for securities. It offers financial services to the clients by giving them access to trade the Philippine market with the support and assistance of a seasoned broker. The company's business segments include: Proprietary Trading, Brokerage Services, Investment Income, and Client Advisory. Its internship program, trader training, and client advisory business allow its clients and stakeholders to participate in the capital markets.
44GF Score

Get the complete analysis for PHS:CTS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱0.36
Price
₱0.47
GF Value